Omicron less severe than Delta but still poses danger for unvaccinated: WHO

By

By Reuters Staff

(Reuters) - The highly infectious Omicron coronavirus variant causes less severe disease than the Delta strain but it remains a "dangerous virus", particularly for those who are unvaccinated, the head of the World Health Organization (WHO) said on Wednesday.

Speaking at a news briefing, director general Tedros Adhanom Ghebreyesus said more than 90 countries were yet to meet the target of vaccinating 40% of their populations and more than 85% of people in Africa were yet to receive a single dose.

"We mustn't allow this virus a free ride or wave the white flag, especially when so many people around the globe remain unvaccinated," he said.

In its weekly epidemiological report on Tuesday, the WHO said cases increased by 55%, or 15 million, in the week to Jan. 9 from a week earlier - by far the most cases reported in a single week.

"This huge spike in infections is being driven by the Omicron variant, which is rapidly replacing Delta in almost all countries," Tedros said.

He said the majority of people hospitalized around the world with COVID-19 were unvaccinated and that if transmission was not curtailed there was greater risk of another variant emerging that could be even more transmissible, and more deadly, than Omicron.

Related Articles

UPDATE 1-U.S. suicide hotline 988 is set to go live, but many states may not be ready

(Adds Lifeline calls in Washington and Wyoming, paragraph 10) By Barbara Goldberg NEW YORK (Reuters) - In just six months, 988 goes live as the shortcut to call or text the U.S. suicide hotline at a Read More »

COLUMN-A quiet experiment is testing broader privatization of U.S. Medicare

(The opinions expressed here are those of the author, a columnist for Reuters.) By Mark Miller (Reuters) - Millions of retirees have opted out of traditional Medicare over the past two decades, Read More »

EMA lists rare spinal condition as side effect of AstraZeneca's COVID-19 shot

By Reuters Staff (Reuters) - A safety panel of the European drug regulator on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca's COVID-19 Read More »